Outlook Therapeutics, Inc. (OTLK) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2019 | $437.3K | -84.3% |
| 2018 | $2.78M | +852.2% |
| 2017 | $292.1K | -73.4% |
| 2016 | $1.10M | -87.5% |
| 2015 | $8.80M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2019 | $437.3K | -84.3% |
| 2018 | $2.78M | +852.2% |
| 2017 | $292.1K | -73.4% |
| 2016 | $1.10M | -87.5% |
| 2015 | $8.80M | — |